Exchanges could channel subsidies, specify plan design and provide an efficient way to enroll members
The Massachusetts Health Connector, for example, has helped achieve nearly universal coverage in the state by offering individuals and small businesses access to a range of coverage options. Many states and the federal government operate what are essentially exchanges for employee benefit plans, and Medicare serves as an exchange for seniors seeking coverage through Medicare Advantage plans.
Exchanges can channel subsidies to low-income individuals, specify plan designs and coverage, and provide an efficient way to educate and enroll large populations.
REFORM PROPOSALS
Health reform bills before Congress establish various exchanges to carry out those functions. The Senate Health, Education, Labor and Pensions (HELP) Committee bill proposes an Affordable Health Benefit Gateway in each state. The Senate Republicans also opt for state-based exchanges, while the House bill creates a national Health Insurance Exchange that will sell plans to individuals, phasing in small and large employers over time.
Exchanges have many features in common. They identify individuals who are eligible to purchase coverage through the program and ensure that health plans offer essential benefits and meet coverage requirements. They can distribute subsidies or tax credits to help lower-income individuals purchase coverage and create a vehicle for enrolling millions of individuals in plans.
There also is variation in how exchanges are governed, how they relate to other health programs such as Medicaid, and the process for private plans to market services through the exchange.
Analysts note a number of trade-offs in how exchanges may affect the healthcare system, says Avalere Health Manager Caroline Pearson. If the exchange lets in larger employer groups, it expands the risk pool, but can erode current coverage options. Providing subsidies only to individuals who purchase through the exchange ensures a large customer base, but one that is sicker and riskier.
State exchanges can respond better to local preferences, while federal operations may achieve more economies of scale and support portability. Flexibility in benefit design may expand choices for consumers, but lead to risk selection within the exchange. There is debate about whether the exchange should negotiate plan bids or serve as a passive operator that merely lists qualifying plans.
The most contentious issue of course is whether an exchange should offer a public plan, as proposed by Congressional Democrats. Opponents claim that private plans cannot compete on a level playing field with a government-run operation. Instead, legislation should establish exchanges that offer private plans operating under new market requirements and see how well that approach provides quality coverage.
Jill Wechsler, a veteran reporter, has been covering Capitol Hill since 1994.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More